Journal
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Volume 101, Issue 3, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2021.115468
Keywords
SARS-CoV-2 diagnostic testing; Cepheid XpertXpress; COVID-19; SARS-CoV-2; single nucleotide polymorphisms
Categories
Funding
- Centers for Disease Control and Prevention (CDC) ELC Enhanced Detection grant
- University of Pittsburgh COVID Medical Response Office
- University of Pittsburgh Medical Center Infection Prevention
Ask authors/readers for more resources
Nasal and nasopharyngeal swab specimens tested by Cepheid Xpert Xpress SARS-CoV-2 were analyzed by whole-genome sequencing based on impaired detection of the N2 target. Each viral genome had at least one mutation in the N gene, which likely arose independently in the New York City and Pittsburgh study sites.
Nasal and nasopharyngeal swab specimens tested by the Cepheid Xpert Xpress SARS-CoV-2 were analyzed by whole-genome sequencing based on impaired detection of the N2 target. Each viral genome had at least one mutation in the N gene, which likely arose independently in the New York City and Pittsburgh study sites. (c) 2021 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
